{"nctId":"NCT00315445","briefTitle":"The Safety and Efficacy of the Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Back Pain.","startDateStruct":{"date":"1997-12"},"conditions":["Back Pain"],"count":134,"armGroups":[{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo oxycodone/acetaminophen tablets","Drug: Placebo transdermal patch (TDS)"]},{"label":"OXY/APAP","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: OXY/APAP"]},{"label":"BTDS","type":"EXPERIMENTAL","interventionNames":["Drug: Buprenorphine transdermal patch"]}],"interventions":[{"name":"Buprenorphine transdermal patch","otherNames":["Butrans™"]},{"name":"Placebo oxycodone/acetaminophen tablets","otherNames":[]},{"name":"OXY/APAP","otherNames":[]},{"name":"Placebo transdermal patch (TDS)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* clinical evidence of stable, chronic (\\>2 months) back pain related to intervertebral disc disease, nerve root entrapment, spondylolithesis, and osteoarthritis or other, similar nonmalignant conditions.\n* unacceptable pain control despite currently taking a nonsteroidal anti-inflammatory drug considered at a therapeutic and/or tolerated dose or, subjects currently taking \\</=2 short-acting opioid doses per day, or subjects taking 3-12 short-acting opioid doses per day.\n\nExclusion Criteria:\n\n* receiving opioids at an average daily dose of \\>90 mg of oral morphine equivalents or receiving more than 12 tablets per day of short-acting opioid-containing products.\n* scheduled to have surgery (including dental) involving the use of preoperative or postoperative analgesics or anesthetics during the study period.\n\nOther protocol-specific exclusion/inclusion criteria may apply.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Pain on the Average, Mean Change From Baseline Days 21-84 (Last Observation Carried Forward [LOCF])","description":"Subjects were asked, \"Please rate your pain by circling the one number (0-10) that best describes your pain on the average since your last visit.\" 0 = no pain and 10 = pain as bad as you can imagine it.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.01","spread":"0.37"},{"groupId":"OG001","value":"-1.82","spread":"0.36"},{"groupId":"OG002","value":"-1.92","spread":"0.34"}]}]}]},{"type":"SECONDARY","title":"\"Physical Functioning\" Scale of the Medical Outcomes Survey (MOS) 36 Item Short-Form Health Survey (SF-36): Mean Percent ± Standard Error of the Mean (SEM) at Day 84 (LOCF)","description":"The Medical Outcomes Survey (MOS) Short-Form-36 Health Survey (SF-36) assesses 8 categories of functionality through 36 individual questions. \"Physical Functioning\" is 1 of the 8 categories. Its transformed score, scaled from 0% to 100%, is used. A higher score represents a better subject condition. The survey was completed by the subject at the clinic. The mean scores were analyzed.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"46.4","spread":"4.0"},{"groupId":"OG001","value":"44.5","spread":"3.9"},{"groupId":"OG002","value":"46.5","spread":"3.6"}]}]}]},{"type":"SECONDARY","title":"\"Physical Role\" Scale (MOS SF-36): Mean Percent ± SEM at Day 84(LOCF)","description":"The Medical Outcomes Survey Short-Form-36 health survey assesses 8 categories of functionality through 36 individual questions. \"Physical Role\" is 1 of the 8 categories. Its transformed score, scaled from 0% to 100%, is used. A higher score represents a better subject condition. The survey was completed by the subject at the clinic. The mean scores were analyzed.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18.9","spread":"4.8"},{"groupId":"OG001","value":"24.4","spread":"5.9"},{"groupId":"OG002","value":"33.9","spread":"5.8"}]}]}]},{"type":"PRIMARY","title":"Pain Right Now, Mean Change From Baseline, Days 21-84 (LOCF)","description":"Subjects were asked, \"Please rate your pain by circling the one number (0-10) that tells how much pain you have right now.\" Subjects rated their answers on a 0-10 ordinal scale from 0 = \"No pain\" to 10 = \"Pain as bad as you can imagine it.\" Pain right now is presented as the LSmean \\[change from baseline\\] (SE).","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.80","spread":"0.38"},{"groupId":"OG001","value":"-1.53","spread":"0.37"},{"groupId":"OG002","value":"-1.66","spread":"0.34"}]}]}]},{"type":"SECONDARY","title":"\"Bodily Pain\" (MOS SF-36): Mean Percent at Day 84 (LOCF)","description":"The MOS Short-Form Health Survey assesses 8 categories of functionality through 36 individual questions. \"Bodily Pain\" is 1 of the 8 categories. Its transformed score, scaled from 0% to 100%, is used. A higher score represents a better subject condition. The survey was completed by the subject at the clinic. The mean scores were analyzed.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"35.3","spread":"3.1"},{"groupId":"OG001","value":"39.0","spread":"3.4"},{"groupId":"OG002","value":"41.9","spread":"3.1"}]}]}]},{"type":"SECONDARY","title":"\"General Health\" (MOS SF-36): Mean Percent ± SEM at Day 84 (LOCF)","description":"The MOS Short-Form Health Survey assesses 8 categories of functionality through 36 individual questions. \"General Health\" is 1 of the 8 categories. Its transformed score, scaled from 0% to 100%, is used. A higher score represents a better subject condition. The survey was completed by the subject at clinic. The mean scores were analyzed.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"52.4","spread":"3.5"},{"groupId":"OG001","value":"52.5","spread":"3.5"},{"groupId":"OG002","value":"57.7","spread":"3.4"}]}]}]},{"type":"SECONDARY","title":"\"Vitality\" (MOS SF-36): Mean Percent ± SEM at Day 84 (LOCF)","description":"The MOS Short-Form Health Survey assesses 8 categories of functionality through 36 individual questions. \"Vitality\" is 1 of the 8 categories. Its transformed score, scaled from 0% to 100%, is used. A higher score represents a better subject condition. The survey was completed by the subject at the clinic. The mean scores were analyzed.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"39.0","spread":"3.7"},{"groupId":"OG001","value":"42.9","spread":"3.7"},{"groupId":"OG002","value":"41.2","spread":"3.5"}]}]}]},{"type":"SECONDARY","title":"\"Social Functioning\" (MOS SF-36): Mean Percent ± SEM at Day 84 (LOCF)","description":"The MOS Short-Form Health Survey assesses 8 categories of functionality through 36 individual questions. \"Social Functioning\" is 1 of the 8 categories. Its transformed score, scaled from 0% to 100%, is used. A higher score represents a better subject condition. The survey was completed by the subject at the clinic.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"53.3","spread":"4.2"},{"groupId":"OG001","value":"59.5","spread":"3.9"},{"groupId":"OG002","value":"65.2","spread":"4.4"}]}]}]},{"type":"SECONDARY","title":"\"Emotional Role\" (MOS SF-36): Mean Percent ± SEM at Day 84 (LOCF)","description":"The MOS Short-Form Health Survey assesses 8 categories of functionality through 36 individual questions. \"Emotional Role\" is 1 of the 8 categories. Its transformed score, scaled from 0% to 100%, is used. A higher score represents a better subject condition. The survey was completed by the subject at the clinic.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"55.3","spread":"6.7"},{"groupId":"OG001","value":"56.3","spread":"7.1"},{"groupId":"OG002","value":"63.0","spread":"6.2"}]}]}]},{"type":"SECONDARY","title":"\"Mental Health\" (MOS SF-36):Mean Percent ± SEM at Day 84 (LOCF)","description":"The MOS Short-Form Health Survey assesses 8 categories of functionality through 36 individual questions. \"Mental Health\" is 1 of the 8 categories. Its transformed score, scaled from 0% to 100%, is used. A higher score represents a better subject condition. The survey was completed by the subject at the clinic.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"67.4","spread":"3.1"},{"groupId":"OG001","value":"68.8","spread":"2.7"},{"groupId":"OG002","value":"67.8","spread":"3.3"}]}]}]},{"type":"SECONDARY","title":"Therapeutic Response - Investigator: Mean ± SEM (Day 84)(LOCF)","description":"The therapeutic response was rated by the investigator. The assessment was completed by the investigator using a 0-3 ordinal scale from 0 = \"No response\" to 3 = \"Marked response.\"","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"0.2"},{"groupId":"OG001","value":"2.0","spread":"0.2"},{"groupId":"OG002","value":"1.9","spread":"0.2"}]}]}]},{"type":"SECONDARY","title":"Therapeutic Response - Subject: Mean ± SEM (Day 84) (LOCF)","description":"The therapeutic response was rated by the subject. The assessment was completed by the subject using a 0-3 ordinal scale from 0 = \"No response\" to 3 = \"Marked response.\"","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"0.2"},{"groupId":"OG001","value":"2.1","spread":"0.1"},{"groupId":"OG002","value":"2.0","spread":"0.2"}]}]}]},{"type":"SECONDARY","title":"Subject Comparison to Prestudy Analgesic: Mean ± SEM (Day 84)(LOCF)","description":"The subject compared study drug treatment to prestudy analgesic. The assessment was completed by the subject using a 0-2 ordinal scale from 0 = \"Worse than prestudy medicine\" to 2 = \"Better than prestudy medicine.\"","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9","spread":"0.1"},{"groupId":"OG001","value":"1.4","spread":"0.1"},{"groupId":"OG002","value":"1.4","spread":"0.1"}]}]}]},{"type":"SECONDARY","title":"Subject Satisfaction: Mean ± SEM (Day 84)(LOCF)","description":"The subject assessed satisfaction with study drug. The assessment was completed by the subject using a 0-3 ordinal scale from 0 = \"No response\" to 3 = \"Marked response.\"","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.2","spread":"0.1"},{"groupId":"OG001","value":"1.8","spread":"0.1"},{"groupId":"OG002","value":"1.7","spread":"0.2"}]}]}]},{"type":"SECONDARY","title":"Time to Stable Pain Management","description":"For each subject, \"time to stable pain management\" is defined as the first (post-baseline) time during the titration period when his/her \"diary pain\" was 4 or less (or at least 2 points lower than baseline) for 3 consecutive daily records or the \"pain on the average\" (at the day 7 or day 21 visit) was 4 or less (or at least 2 points lower than baseline).","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"7","spread":null},{"groupId":"OG002","value":"7","spread":null}]}]}]},{"type":"SECONDARY","title":"The Time to Discontinuation Due to Lack of Efficacy","description":"Dropouts due to various reasons were summarized by counts and percentage. Cox proportional hazards regression was used to assess the treatment differences in time to dropout due to lack of efficacy. Clinically important covariates (including gender, age, race, weight, baseline pain, and previous opioid use) were incorporated into the model when statistically significant at P\\< .10, using a backward elimination procedure.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":null},{"groupId":"OG001","value":"NA","spread":null},{"groupId":"OG002","value":"NA","spread":null}]}]}]},{"type":"POST_HOC","title":"Sensitivity Analysis: \"Pain on the Average\" Change From Baseline in the Maintenance Period (Days 21 - 84) Baseline Observation Carried Forward (BOCF)","description":"Subjects were asked, \"Please rate your pain by circling the one number (0-10) that best describes your pain on the average since your last visit.\" 0 = no pain and 10 = pain as bad as you can imagine it.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.77","spread":"0.38"},{"groupId":"OG001","value":"-1.70","spread":"0.38"},{"groupId":"OG002","value":"-1.74","spread":"0.35"}]}]}]},{"type":"POST_HOC","title":"Sensitivity Analysis: \"Pain Right Now\" Change From Baseline in the Maintenance Period (Days 21-84), BOCF","description":"Subjects were asked, \"Please rate your pain by circling the one number (0-10) that tells how much pain you have right now.\" Subjects rated their answers on a 0-10 ordinal scale from 0 = \"No pain\" to 10 = \"Pain as bad as you can imagine it.\" Primary back pain was measured.","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.53","spread":"0.37"},{"groupId":"OG001","value":"-1.46","spread":"0.37"},{"groupId":"OG002","value":"-1.64","spread":"0.33"}]}]}]},{"type":"POST_HOC","title":"Sensitivity Analysis \"Pain on the Average\" Change From Baseline in the Maintenance Period (Days 21-84) (Hybrid BOCF/LOCF)","description":"Subjects were asked, \"Please rate your pain by circling the one number (0-10) that best describes your pain on the average since your last visit.\" 0 = no pain and 10 = pain as bad as you can imagine it.\n\nThis is a multiple imputation method that requires imputed changes from baseline to be stratified by discontinuation (D/C) reason. If subject D/C'd due to AE, the baseline observation was carried forward (ie, BOCF method of imputation). If subject D/C'd other than for an AE, the last missing data prior to D/C of study drug was carried forward (ie, LOCF method of imputation).","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.91","spread":"0.39"},{"groupId":"OG001","value":"-1.77","spread":"0.39"},{"groupId":"OG002","value":"-1.86","spread":"0.35"}]}]}]},{"type":"POST_HOC","title":"Sensitivity Analysis: \"Pain Right Now\" Change From Baseline in the Maintenance Period (Days 21-84) (Hybrid BOCF/LOCF)","description":"Subjects were asked, \"Please rate your pain by circling the one number (0-10) that tells how much pain you have right now.\" Subjects rated their answers on a 0-10 ordinal scale from 0 = \"No pain\" to 10 = \"Pain as bad as you can imagine it.\"\n\nThis is a multiple imputation method that requires imputed changes from baseline to be stratified by discontinuation (D/C) reason. If subject D/C'd from study due to AE, the baseline observation was carried forward (BOCF). If subject D/C'd from study other than for AE, the last missing data prior to D/C of study drug was carried forward (LOCF).","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.78","spread":"0.38"},{"groupId":"OG001","value":"-1.60","spread":"0.38"},{"groupId":"OG002","value":"-1.59","spread":"0.34"}]}]}]},{"type":"POST_HOC","title":"Sensitivity Analysis: \"Pain on the Average\" Change From Baseline to End of Treatment (Day 84) (Hybrid BOCF/LOCF)","description":"Subjects were asked, \"Please rate your pain by circling the one number (0-10) that best describes your pain on the average since your last visit.\" 0 = no pain and 10 = pain as bad as you can imagine it.\n\nThis is a multiple imputation method that requires imputed changes from baseline to be stratified by discontinuation (D/C) reason. If subject D/C'd due to AE, the baseline observation was carried forward (ie, BOCF method of imputation). If subject D/C'd other than for an AE, the last missing data prior to D/C of study drug was carried forward (ie, LOCF method of imputation).","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.44","spread":"0.44"},{"groupId":"OG001","value":"-1.47","spread":"0.44"},{"groupId":"OG002","value":"-1.70","spread":"0.40"}]}]}]},{"type":"POST_HOC","title":"Sensitivity Analysis: \"Pain Right Now\" Change From Baseline to End of Treatment (Day 84) (Hybrid BOCF/LOCF)","description":"Subjects were asked, \"Please rate your pain by circling the one number (0-10) that tells how much pain you have right now.\" Subjects rated their answers on a 0-10 ordinal scale from 0 = \"No pain\" to 10 = \"Pain as bad as you can imagine it.\"\n\nThis is a multiple imputation method that requires imputed changes from baseline to be stratified by discontinuation (D/C) reason. If subject D/C'd from study due to AE, the baseline observation was carried forward (BOCF). If subject D/C'd from study other than for AE, the last missing data prior to D/C of study drug was carried forward (LOCF).","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.30","spread":"0.45"},{"groupId":"OG001","value":"-1.56","spread":"0.45"},{"groupId":"OG002","value":"-1.50","spread":"0.41"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":45},"commonTop":["Nausea","Dizziness","Somnolence","Constipation","Headache"]}}}